John McGillicuddy
John Francis McGillicuddy | |
|---|---|
| Born | Template:Birth date |
| Died | January 4, 2009 (aged 78) Harrison, New York, U.S. |
| Occupation | Banking executive |
| Known for | Chairman and CEO of Manufacturers Hanover Trust; orchestrated 1991 merger with Chemical Bank |
John Francis McGillicuddy (December 30, 1930 – January 4, 2009) was a prominent American banking leader recognized for his pivotal role in the early 1990s merger of Manufacturers Hanover Trust with Chemical Bank.
McGillicuddy earned a football scholarship to attend Princeton University and subsequently graduated from Harvard Law School. Following his service in the United States Navy, he began his legal career at Simpson Thacher & Bartlett before joining Manufacturers Trust Company in 1958. At just 39 years old, he was appointed president of the bank in 1970, making him one of the youngest executives to head a major financial institution.
In the 1970s, McGillicuddy was instrumental in coordinating financial support to aid New York City during its fiscal emergency and later facilitated government-backed loan guarantees that helped avert Chrysler’s bankruptcy.
As chairman and CEO of Manufacturers Hanover, he masterminded the 1991 merger with Chemical Banking Corporation, which at the time was the largest banking consolidation in U.S. history. He led the merged entity as chairman and CEO until his retirement in 1993, after which Chemical’s chairman Walter V. Shipley took over.
This landmark merger set off a series of consolidations culminating in Chemical’s acquisition of Chase Manhattan Corporation in 1996 and its subsequent merger with J.P. Morgan & Co. in 2000, forming what is now known as JPMorgan Chase & Co..
Beyond banking, McGillicuddy held board positions with major corporations such as Kraft Foods, United Airlines, and U.S. Steel, as well as with nonprofit organizations including the Boy Scouts of America.
He passed away at his residence in Harrison, New York on January 4, 2009, at age 78, due to complications from prostate cancer.